Full history for every metric is available with a Kvantra account
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 3,823 | 4,197 | 5,642 | 5,425 | 3,976 | 4,107 | 4,072 | 3,753 |
| Operating profit | $m | 366 | 396 | ||||||
| Net profit | $m | 175 | 167 | 200 | 354 | 171 | 191 | 235 | 360 |
| EPS reported | $ | 0.75 | 0.96 | ||||||
| Operating cashflow per share | $ | 1.58 | 1.80 | ||||||
| Capex per share | $ | 0.21 | 0.24 | ||||||
| FCF per share | $ | 1.38 | 1.56 | ||||||
| Free cash flow | $m | 345 | 377 | ||||||
| Net debt | $m | 526 | 832 | ||||||
| Book value equity | $m | 1,927 | 1,896 | ||||||
| Book value per share | $ | 7.62 | 7.79 | ||||||
| Number of shares | m | 253.03 | 243.52 | ||||||
| DPS (TTM paid) | $ | 0.50 | 0.52 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 22.85 | - | ||||||
| P/B LTM | x | 1.90 | 2.71 | ||||||
| P/S LTM | x | 0.89 | 1.26 | ||||||
| P/FCF LTM | x | 10.60 | 13.61 | ||||||
| EV/EBITDA LTM | x | 8.24 | 11.14 | ||||||
| EV/Sales LTM | x | 1.04 | 1.46 | ||||||
| Earnings Yield LTM | % | 4.38% | 4.58% | ||||||
| FCF Yield | % | 9.44% | 7.35% | ||||||
| Quality | |||||||||
| ROE | % | 9.90% | 12.30% | ||||||
| ROIC | % | 10.16% | 10.70% | ||||||
| Operating margin | % | 8.90% | 9.72% | ||||||
| Gross margin | % | 24.99% | 25.67% | ||||||
| FCF/Sales | % | 8.40% | 9.26% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +17.19% | +104.26% | ||||||
| Sales Growth YoY | % | +3.30% | +0.01% | ||||||
| Net Income Growth YoY | % | +11.86% | +96.22% | ||||||
| FCF Growth | % | -3.14% | +23.67% | ||||||
| Operating Profit Growth | % | +50.40% | +103.21% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 3.35% | 2.42% | ||||||
| Dividend Growth | % | +16.46% | +14.52% | ||||||
| Payout Ratio | % | 64.61% | 64.27% | ||||||
| FCF/Debt | x | 0.31 | 0.31 | ||||||
| Net Debt/EBITDA | x | 1.22 | 1.55 | ||||||
| EBIT/Net interest | x | 11.04 | 11.58 | ||||||
| Net debt/market cap | % | 14.39% | 16.22% | ||||||
| Net debt/Equity | x | 0.27 | 0.44 | ||||||
| Gross debt/equity | x | 0.58 | 0.64 | ||||||
ETFs that hold Glanbia
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| First Trust Eurozone AlphaDEX UCITS ETF | FTEU.L | 9 | 1.17% |
| First Trust Eurozone AlphaDEX ETF | FEUZ | 9 | 1.18% |
| iShares MSCI Ireland ETF | EIRL | 8 | 3.89% |
Funds with Glanbia among their ten largest holdings, largest fund first.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| First Trust Eurozone AlphaDEX UCITS ETF | FTEU.L | 9 | 1.17% |
| First Trust Eurozone AlphaDEX ETF | FEUZ | 9 | 1.18% |
| iShares MSCI Ireland ETF | EIRL | 8 | 3.89% |
Funds with Glanbia among their ten largest holdings, largest fund first.
Based on consensus from external analysts. Not Kvantra's opinion.
Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free